Centre National de la Recherche Scientifique (C.N.R.S);Universite de la Mediterranee Aix-Marseille II
发明人:
Dono, Rosanna,Fico, Annalisa,Maina, Flavio
申请号:
AU2011284651
公开号:
AU2011284651A1
申请日:
2011.07.29
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The present invention thus relates to stem cells or progenitor cells wherein the expression and/or activity of a member of the glypican family is reduced or abolished for use for the treatment of a pathological condition selected from the group consisting of a degenerative disease, a cardiac disorder, a metabolic disease and an injury by stem cell- based therapy.